HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt

This article was originally published in The Tan Sheet

Executive Summary

An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement

You may also be interested in...

FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement

FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say

Science, FDA Rule Support Centrum Cardio Claims, Wyeth Will Tell Congress

Wyeth says both science and FDA support the claims for Centrum Cardio that the House Energy and Commerce Committee is questioning

Phytosterol CHD Health Claim Expanded Interim Use Permitted By FDA

FDA will allow the use of a phytosterol heart health claim on a broader range of foods, beverages and dietary supplements while it completes a final rule on the issue, according to a Feb. 14 open letter posted on the agency's Web site





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts